Paroxetine maleate

Suppliers

Names

[ CAS No. ]:
64006-44-6

[ Name ]:
Paroxetine maleate

[Synonym ]:
fg7051maleate
gf74
MFCD01742665
Paroxetine maleate

Chemical & Physical Properties

[ Density]:
1.213 g/cm3

[ Boiling Point ]:
451.7ºC at 760 mmHg

[ Melting Point ]:
136-138ºC

[ Molecular Formula ]:
C23H24FNO7

[ Molecular Weight ]:
445.44

[ Flash Point ]:
227ºC

[ Exact Mass ]:
445.15400

[ PSA ]:
114.32000

[ LogP ]:
3.36710

[ Storage condition ]:
2-8°C

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
TM4569300
CHEMICAL NAME :
Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl )-, trans-(-)-, (Z)-2- butenedioate
CAS REGISTRY NUMBER :
64006-44-6
LAST UPDATED :
199707
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C19-H20-F-N-O3.xC4-H4-O4
MOLECULAR WEIGHT :
1141.96

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
6700 ug/kg
TOXIC EFFECTS :
Behavioral - excitement
REFERENCE :
AJEMEN American Journal of Emergency Medicine. (WB Saunders, Philadelphia, PA) V.1- 1983- Volume(issue)/page/year: 11,682,1993
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4007196
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
845 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
85KYAH "Merck Index; an Encyclopedia of Chemicals, Drugs, and Biologicals", 11th ed., Rahway, NJ 07065, Merck & Co., Inc. 1989 Volume(issue)/page/year: 11,1114,1989

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H302-H315-H319-H335

[ Precautionary Statements ]:
P261-P305 + P351 + P338

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Faceshields;Gloves

[ Hazard Codes ]:
Xn: Harmful;

[ Risk Phrases ]:
R22;R36/37/38

[ Safety Phrases ]:
S26-S36

[ RIDADR ]:
UN 3249

[ WGK Germany ]:
3

[ RTECS ]:
TM4569300

[ Packaging Group ]:
III

[ Hazard Class ]:
6.1(b)

Articles

A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.

J. Clin. Psychopharmacol. 33(1) , 3-10, (2013)

The potential for iloperidone, a D2/5-HT2A antipsychotic, to affect the heart rate-corrected QT interval (QTc) was assessed in the absence and presence of metabolic inhibitors in a randomized, open-la...

Chronic angle-closure glaucoma related to paroxetine treatment.

Semin. Ophthalmol. 28(4) , 244-6, (2013)

To present a unique case of a 33-year-old woman using paroxetine who presented with acute unilateral visual loss due to chronic angle-closure glaucoma.Case report.A 33-year-old women who had been unde...

Paroxetine (Brisdelle) for hot flashes.

Med. Lett. Drugs Ther. 55(1428) , 85-6, (2013)


More Articles


Related Compounds

  • PAROXETINE-D6 MALEATE
  • Paroxetine hydrochloride hydrate
  • Paroxetine EP Impurity H HCl
  • (3S,4R)-trans-1-benzyloxycarbonyl-4-(4-fluorophenyl)-3-[(3,4-methylenedioxyphenyl)oxymethyl]piperidine
  • Paroxetine
  • Paroxetine-d4 hydrochloride
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • ethyl 2-(((4,6-dioxo-2-thioxotetrahydropyrimidin-5(2H)-ylidene)methyl)amino)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 2-(4-Isobutoxy-3-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • tert-Butyl-DL-alanine